Literature DB >> 947408

Immunosuppressive therapy of Factor VIII inhibitors.

M B Hultin, S S Shapiro, H S Bowman, F M Gill, A T Andrews, J Martinez, E M Eyster, W C Sherwood.   

Abstract

Immunosuppressive therapy was used in seven hemophiliac and three nonhemophiliac patients with factor VIII inhibiors. Permanent disappearance of the inhibitor occurred in three hemophiliac and two nonhemophiliac patients following treatment with cyclophosphamide and factor VIII. Critical factors influencing the response to therapy may include both the titer and duration of the inhibitor and the degree of intervening factor VIII exposure prior to immunosuppressive therapy. Two severe hemophiliacs with low titer inhibitors that disappeared without specific therapy are also reported.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 947408

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

Review 1.  Immunologically generated circulating anticoagulants in humans.

Authors:  R L Edwards; C J Wakem
Journal:  Surv Immunol Res       Date:  1984

2.  Haemophilia due to factor VIII inhibitors in a patient suffering from an autoimmune disease: treatment with intravenous immunoglobulin. A case report.

Authors:  A Gianella-Borradori; A Hirt; A Lüthy; H P Wagner; P Imbach
Journal:  Blut       Date:  1984-06

3.  TIMP‑3 suppresses the proliferation and migration of SMCs from the aortic neck of atherosclerotic AAA in rabbits, via decreased MMP‑2 and MMP‑9 activity, and reduced TNF‑α expression.

Authors:  Huan Zhai; Xun Qi; Zixuan Li; Wei Zhang; Chenguang Li; Lu Ji; Ke Xu; Hongshan Zhong
Journal:  Mol Med Rep       Date:  2018-06-26       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.